Oral Answers to Questions

Alison Bennett Excerpts

Tuesday 20th October 2026 Commons Chamber

[Dame Diana Johnson]

I recognise that some women exposed to DES still face difficulties accessing advice, monitoring and referral. Clinicians should consider individual medical histories, symptoms and risk factors. I had a look at the letter that was sent on 12 December explaining what more should be done by clinicians. I will again ask officials to look at whether we need to reissue that letter or whether we need to take any other action to ensure that the information about DES is spread as widely as possible among clinicians.

[Alison Bennett (Mid Sussex) (LD)]

I am pleased that the Minister is talking about ensuring that medical professionals are more aware of DES and the risks for those who were potentially exposed to it, but what is her assessment of the feasibility of tracking and informing those who were potentially exposed? My constituent Heather did not realise that she—or her mother—had been exposed until long after her mother’s death.

[Dame Diana Johnson]

As I just said, the Government are improving identification and support for people affected by DES by raising awareness among clinicians and strengthening the dissemination of existing NHS guidance. There are considerable challenges associated with recalling records from the 1940s to the 1970s, particularly because of the record-keeping practices of that era and the fact that the Medicines and Healthcare products Regulatory Agency had not yet been established at that time, but I am mindful of the point that the hon. Member makes.